Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma
在复发/难治性侵袭性B细胞淋巴瘤中,研究性Aurora A激酶抑制剂Alisertib联合利妥昔单抗或利妥昔单抗/长春新碱的I期研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-18-0286
Kelly, Kevin R; Friedberg, Jonathan W; Park, Steven I; McDonagh, Kevin; Hayslip, John; Persky, Daniel; Ruan, Jia; Puvvada, Soham; Rosen, Peter; Iyer, Swaminathan Padmanabhan; Stefanovic, Alexandra; Bernstein, Steven H; Weitman, Steven; Karnad, Anand; Monohan, Gregory; VanderWalde, Ari; Mena, Raul; Schmelz, Monika; Spier, Catherine; Groshen, Susan; Venkatakrishnan, Karthik; Zhou, Xiaofei; Sheldon-Waniga, Emily; Leonard, E Jane; Mahadevan, Daruka
B细胞
信号转导
Aurora A
淋巴瘤
细胞生物学
免疫/内分泌